Cadrenal Therapeutics, Inc.

CVKD

$4.31▲ 2.86% 24h

Advanced chart & tools →

Cadrenal Therapeutics, Inc.CVKD

$4.31

+$1.97(+84.21%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

$10.80M

P/E ratio

—

EPS (diluted)

$-6.64

Dividend yield

382.83%

Dividend / share

$16.50

Revenue

—

Net income

$-13.24M

Net margin

—

Gross margin

—

Dividends & financials

Cadrenal Therapeutics, Inc. (CVKD) reported revenue of — and net income of $-13.24M, or $-6.64 per diluted share. It pays an annual dividend of $16.50 per share — a yield of 382.83% at the current price. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.